NCT01250197View on ClinicalTrials.gov

Formulation Comparison in Normal Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Normal Volunteers
Interventions
DRUG

AR-12286

Ophthalmic Solution

Trial Locations (1)

85283

Celerion, Phoenix

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT01250197 - Formulation Comparison in Normal Volunteers | Biotech Hunter | Biotech Hunter